Fairmount Funds Management LLC - Director at Spyre Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Company
Role: Director
Stock Symbol: SYRE on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

There are no Buy or Sell transactions made by Fairmount Funds Management LLC since 3/10/2024

Holdings reported by Fairmount Funds Management LLC for Spyre Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	4.02M	$2.85M	$0.71	Apr 25, 2024	By Fairmount Healthcare Fund II L.P.
Common Stock	406K	$288K	$0.71	Apr 25, 2024	By Peter Harwin
Common Stock	406K	$288K	$0.71	Apr 25, 2024	By Tomas Kiselak
Series A Preferred Stock	346K			Apr 25, 2024	By Fairmount Healthcare Fund II L.P.	Common Stock	17.5M
Series B Preferred Stock	16.7K			Dec 29, 2023	By Fairmount Healthcare Fund II L.P.	Common Stock	667K
Stock Option (Right to Buy)	11.3K			May 14, 2024	By Peter Harwin	Common Stock
Stock Option (Right to Buy)	11.3K			May 14, 2024	By Tomas Kiselak	Common Stock

Showing 1 to 7 of 7 entries

Transactions reported by Fairmount Funds Management LLC for Spyre Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.